WSI Co., Ltd. Logo

WSI Co., Ltd.

Develops, manufactures, and distributes pharmaceuticals and medical devices.

299170 | KO

Overview

Corporate Details

ISIN(s):
KR7299170001
LEI:
Country:
South Korea
Address:
서울특별시 송파구 삼학사로 47(삼전동) -, 서울특별시

Description

WSI Co., Ltd. is a healthcare company engaged in the development, manufacturing, and distribution of pharmaceuticals and medical devices. Founded in 2016, the company focuses on providing safe and technologically advanced products to improve health and well-being. Its portfolio includes a range of medical devices, with a specialization in solutions for spinal joints, as well as pharmaceuticals such as local hemostatic agents and blood substitutes. WSI leverages its professional expertise and a commitment to research and development to deliver innovative and competitive medical solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-30 00:00
전환청구권행사
Korean HTML 19.9 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.4 KB
2025-09-04 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 98.3 KB
2025-09-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 26.0 KB
2025-08-29 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 115.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.6 MB
2025-08-08 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 71.1 KB
2025-08-07 00:00
[기재정정]전환청구권행사
Korean HTML 16.8 KB
2025-08-07 00:00
[기재정정]전환청구권행사
Korean HTML 16.8 KB
2025-08-04 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 66.1 KB
2025-07-30 00:00
전환가액의조정
Korean HTML 16.1 KB
2025-07-29 00:00
전환청구권행사
Korean HTML 13.9 KB
2025-06-16 00:00
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
Korean HTML 91.8 KB
2025-06-12 00:00
전환청구권행사
Korean HTML 10.6 KB
2025-06-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.0 KB

Automate Your Workflow. Get a real-time feed of all WSI Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WSI Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WSI Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.